Dr. Hoskins on the Impact of Race on Breast Cancer Outcomes

In Partnership With:

Partner | Cancer Centers | <b>University of Illinois Cancer Center</b>

Kent Hoskins, MD, discusses the impact of race on breast cancer outcomes.

Kent Hoskins, MD, a VST associate professor in the Department of Medicine, Division of Hematology and Oncology, at The University of Illinois College of Medicine, discusses the impact of race on breast cancer outcomes.

In some cases, there are biologic differences that are associated with race in breast cancer, according to Hoskins. It is important to understand why this occurs and recognize that social determinants can influence biology, Hoskins explains.

When considering issues of health equity and access, it is important to understand how these issues affect multiple levels of the cancer care continuum, including timely care and access, as well as biology, Hoskins says. 

Moreover, as tests that are being developed in populations with a small amount of representation are being applied, it is important to examine the tests to ensure that the results are accurate to all patients of color. One cannot assume that what applies to the greater patient population also applies to all minority groups, Hoskins concludes.